Tag: Sarepta Therapeutics

  • Trending Stocks: T-Mobile US Inc (NYSE:TMUS), Alcoa Inc (NYSE:AA), Sprint Corporation (NYSE:S), J.C. Penney Company (NYSE:JCP), Sarepta Therapeutics Inc (NASDAQ:SRPT)

    T-Mobile US (NYSE:TMUS) CEO John Legere fired back at the Federal Trade Commission, accusing the agency of “sensationalizing” a lawsuit it filed against the carrier for allegedly charging customers hundreds of millions of dollars for purported “premium” SMS subscriptions that, in many cases, customers never authorized. T-Mobile US Inc (NYSE:TMUS) net profit margin is -0.80% and weekly performance is -0.87%. On last trading day company shares ended up $32.99. Analysts mean target price for the company is $34.98. T-Mobile US Inc (NYSE:TMUS) distance from 50-day simple moving average is 0.69%.

    Alcoa (NYSE:AA)‘s stock had its “hold” rating restated by investment analysts at Deutsche Bank in a note issued to investors on Thursday. They currently have a $15.00 price target on the stock, up from their previous price target of $10.00. Alcoa Inc (NYSE:AA) shares fell -1.60% in last trading session and ended the day on $14.74. AA Gross Margin is 16.40% and its return on assets is -7.10%. Alcoa Inc (NYSE:AA) quarterly performance is 16.98%.

    On June 23,2014 Sprint Corporation (NYSE:S) made several network announcements this morning at a press conference in Chicago. Sprint has added more LTE, more Spark, and more HD voice capabilities to additional cities. The 28 markets were not listed individually, but there were expansions in Seattle, Cleveland, and San Jose. Sprint Corporation (NYSE:S) shares moved down -1.16% in last trading session and was closed at $8.50, while trading in range of $8.49-$8.63. Sprint Corporation (NYSE:S) year to date performance is -20.93%.

    J.C. Penney Company, Inc. (NYSE:JCP), has announced its sponsorship of Oklahoma country music star Blake Shelton’s 2014 “Ten Times Crazier” tour. As part of the sponsorship, JCPenney will build on its partnership with Shelton, a JCPenney Cares Ambassador since 2012, to raise awareness and support for America’s troops and military families through donations to the United Service Organizations. J.C. Penney Company, Inc. (NYSE:JCP) ended the last trading day at $9.07. Company weekly volatility is calculated as 2.87% and price to cash ratio as 2.36. J.C. Penney Company, Inc. (NYSE:JCP) showed a positive weekly performance of 1.34%.

    Sarepta Therapeutics (NASDAQ:SRPT) has been given a consensus rating of “Hold” by the nineteen ratings firms that are presently covering the stock. One analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and nine have given a buy recommendation to the company.Sarepta Therapeutics Inc (NASDAQ:SRPT) net profit margin is -11.60% and weekly performance is -8.19%. On last trading day company shares ended up $27.70. Analysts mean target price for the company is $39.58. Sarepta Therapeutics Inc (NASDAQ:SRPT) distance from 50-day simple moving average is -16.44%.